Life Sciences Focus Burns McClellan specializes in public and investor relations for life sciences and healthcare, indicating a deep customer base that includes pharmaceutical, biotech, medical device, and diagnostics firms. This creates cross-sell opportunities for expanded IR, corporate communications, and strategic advisory services within related life sciences segments.

Mid-Sized Scale With 11-50 employees and annual revenue in the $25M-$50M range, the firm sits between boutique and larger agencies, signaling readiness for scalable partnerships, flexible engagement models, and potential collaboration with larger firms on capacity or specialized projects.

Global Access Strategic partnership with Hume Brophy extends Burns McClellan’s reach to European markets, presenting opportunities to co-collaborate on cross-border campaigns, regulatory communications, and international investor relations for clients expanding globally.

Tech Stack Leverage Current use of WordPress, SEO tooling, and common web technologies indicates room to upsell digital marketing services, analytics-driven PR campaigns, and enhanced online content strategies to improve visibility for life sciences brands.

Market Positioning Operating in a competitive space with peers of varying sizes (ICR, FTI, Argot Partners, Russo Partners, etc.), Burns McClellan can position as a specialized, science-forward partner for smaller to mid-market life sciences companies seeking expert storytelling, crisis counsel, and targeted investor outreach.